ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients	Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast carcinoma, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 3	2026-04-17		NCT06195709

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institut Curie	48
Zionexa	1

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Bruno MAUCHERAT	Saint-Herblain	France	1
Centre Antoine Lacassagne	Nice	France	83
Centre de lutte contre le cancer Paul Strauss	Strasbourg	France	1
Centre Eugène Marquis	Rennes	France	42
Centre Francois Baclesse	Caen	France	33
Centre Georges Francois Leclerc	Dijon	France	18
Centre Henri Becquerel	Rouen	France	59
Centre Hospitalier de la Côte Basque	Bayonne	France	11
Centre Leon Bérard	Lyon	France	2
Centre Oscar Lambret	Lille	France	41
CHU Limoges	Limoges	France	14
Hôpital Bretonneau-CHU Tours	Tours	France	1
Hôpital Universitaire de Nimes	Nîmes	France	1
Institut Bergonié	Bordeaux	France	53
Institut Curie	Saint-Cloud	France	19
Institut Curie	Paris	France	81
Institut de Cancerologie de Lorraine	Vandœuvre-lès-Nancy	France	12
Institut du Cancer Montpellier	Montpellier	France	2
Institut Paoli-Calmettes	Marseille	France	35
Oncopole Claudius Regaud	Toulouse	France	17
Polyclinique Bordeaux Nord Aquitaine	Bordeaux	France	8

Clinical trials